Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

Showing session: reset

TUBERCULOSIS, OPPORTUNISTIC INFECTIONS, AND HEPATITIS

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 12 of 12
INTRODUCTION OF SPEAKERS PART I
David L Thomas
The Johns Hopkins School of Medicine, Baltimore, MD, USA
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
NOVEL QPCR APPROACH REVEALS DYNAMICS OF HBSAG DERIVED FROM INTEGRATED HBV (IDNA)   (ABSTRACT 71)
Tanner Grudda
Johns Hopkins University, Baltimore, MD, USA
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
MODELING IMPACT OF THE COVID-19 PANDEMIC ON HEPATITIS C VIRUS ELIMINATION IN THE US   (ABSTRACT 72)
Ricardo E Flores Ortega
University of California San Diego, La Jolla, CA, USA
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
EFFECT OF DIRECT-ACTING ANTIVIRALS ON HCV INCIDENCE AMONG PEOPLE LIVING WITH HIV   (ABSTRACT 73)
Daniela Katinka Van Santen
Burnet Institute, Melbourne, Australia
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
VORICONAZOLE OR AMPHOTERICIN B DEOXYCHOLATE: WHICH IS THE PREFERRED INDUCTION THERAPY   (ABSTRACT 74)
Yaokai Chen
Chongqing Public Health Medical Center, Chongqing, China
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Yaokai Chen
Chongqing Public Health Medical Center, Chongqing, China
David L Thomas
The Johns Hopkins School of Medicine, Baltimore, MD, USA
Ricardo E Flores Ortega
University of California San Diego, La Jolla, CA, USA
Tanner Grudda
Johns Hopkins University, Baltimore, MD, USA
Daniela Katinka Van Santen
Burnet Institute, Melbourne, Australia
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
CLUSTER RCT OF A MID-LEVEL MANAGER INTERVENTION TO PROMOTE IPT UPTAKE IN UGANDA   (ABSTRACT 75)
Elijah Kakande
Infectious Diseases Research Collaboration, , Uganda
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
RANDOMIZED CONTROLLED TRIAL OF ADJUNCTIVE ROSUVASTATIN FOR TUBERCULOSIS TREATMENT   (ABSTRACT 76)
Gail B Cross
National University Of Health Sciences, Singapore, Singapore
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
PK OF DOSE-ADJUSTED EMERGENCY CONTRACEPTION WITH RIFAMPICIN THERAPY IN ACTG A5375   (ABSTRACT 77)
Rosie Mngqibisa
Enhancing Care Foundation, Durban, South Africa
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
DTG PK IN PEOPLE WITH HIV RECEIVING DAILY 1HP FOR LATENT TB TREATMENT (ACTG A5372)   (ABSTRACT 78)
Anthony T Podany
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
TB-PRACTECAL RESULTS: 24 WEEK ALL-ORAL REGIMENS FOR RIFAMPICIN RESISTANT TUBERCULOSIS   (ABSTRACT 79)
Bern-Thomas Nyang'wa
Médecins Sans Frontières, the Netherlands, Amsterdam, Netherlands
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Gail B Cross
National University Of Health Sciences, Singapore, Singapore
Constance A Benson
University of California San Diego, San Diego, CA, USA
Elijah Kakande
Infectious Diseases Research Collaboration, , Uganda
Rosie Mngqibisa
Enhancing Care Foundation, Durban, South Africa
Bern-Thomas Nyang'wa
Médecins Sans Frontières, the Netherlands, Amsterdam, Netherlands
Anthony T Podany
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2022 on February 15, 2022 9:45 AM-11:45 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 12 of 12